Physician profile
Jerry Thomas
NPI 1891475257
$807.99
in general payments reported to CMS, 2019-2025
8 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $457 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $411.58 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $118.02 | 2024 | Spravato |
| Astrazeneca Pharmaceuticals Lp | $64.90 | 2024-2025 | Airsupra, Breztri |
| Amgen INC. | $51.27 | 2024-2025 | Krystexxa, Repatha, Otezla |
| Boston Scientific Corporation | $48.34 | 2025 | General - Pain Management |
| Dexcom, INC. | $46.72 | 2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $43.27 | 2024 | Mounjaro, Zepbound |
| Organon LLC | $23.89 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.